Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Eligible patients with previously untreated, metastatic squamous non–small-cell lung cancer (NSCLC) were randomly assigned 1:1 to pembrolizumab 200 mg or placebo plus carboplatin and ...

A 56-year-old man presented for 3 weeks of intermittent blurred vision and photophobia.His medical history included type 2 diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease ...

The frequency of chromosomal abnormalities in AL amyloidosis and their impact on treatment response. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does not ...

Candel Therapeutics essentially uses a dual-virus strategy with CAN-2409 and CAN-3110 immunotherapies. Find out why CADL ...

More than 7 million people will lose Medicaid coverage over the next 10 years if the bill becomes law, according to the Congressional Budget Office.